HEALTHeUNIVERSE, Inc. (HLUN) Research

Healtheuniverse, Inc. operates as a biotechnology firm dedicated to exploring, creating, and bringing to market a diverse range of biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products. A key focus involves advancing regenerative medicine and stem cell treatments, specifically employing non-embryonic adult stem cells. These therapies are designed for applications across multiple medical specialties, such as reconstructive and plastic surgery, orthopedics, vascular procedures, heart surgery, and wound management. Additionally, the company extends its expertise through consulting services, assisting various enterprises with strategic marketing, organizational structuring, and securing funding for their initiatives. Established in 2001, its primary operational base is located in Covina, California.

Market snapshot

Symbol
HLUN
Price
$0.00
Day change
0.00%
Market cap
$11.8K
52-week range
0.00001-0.0001
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Aridis Pharmaceuticals, Inc. (ARDS)
  • Evelo Biosciences, Inc. (EVLO)
  • Infinity Pharmaceuticals, Inc. (INFIQ)
  • NanoLogix, Inc. (NNLX)
  • Strategic Partners A/S (OZYMF)
  • PaxMedica, Inc. Common Stock (PXMD)
  • Q BioMed Inc. (QBIO)
  • Trevena, Inc. (TRVN)

Open HEALTHeUNIVERSE, Inc. (HLUN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.